Caring Ambassadors Program
The Caring Ambassadors Program in partnership with the National Viral Hepatitis
Roundtable and Hepatitis C Advocates United is pleased to announce our
new Webinar series. Each month we will be hosting an interactive educational
webinar on viral hepatitis. We hope you will actively participate as
we collectively augment our knowledge base from experts in the field.
Liver Cancer and Hepatitis C
Register for this free webinar
Date: Wed., April 3rd
Time: 3 pm EST; 12 pm PST
Douglas LaBrecque, MD
Professor of Medicine and Director of the Liver Service at the University of Iowa. Dr. LaBrecque also served as Chief of GI and Hepatology at the Iowa City VA Hospital for 19 years. He has conducted extensive research on the development and treatment of hepatitis C, hepatitis B, and other liver diseases, including liver transplantation with more than 100 peer-reviewed manuscripts, three books, 22 book chapters and over 150 abstracts.
For more details: www.livercancerconnect.org
2013 Liver Cancer Webinar Series
A dedicated program of the Hepatitis B Foundation
Liver Cancer and Hepatitis B: What You Need to Know
Learn About Liver Cancer
Join the Hepatitis B Foundation's webinar series to learn about the risk factors for liver cancer and the importance of liver cancer screening and surveillance. The expert presenters will describe currently available treatment options and clinical trials.
For More Information
Visit www.LiverCancerConnect.org for accurate, patient-focused information about liver cancer.
Liver Cancer and Hepatitis B
Register for this free webinar
Date: Wed., March 6th
Time: 12 pm EST; 9 am PST
Robert G. Gish, MD
Clinical Professor of Medicine, Section Chief of Hepatology and Co-Director of the Center for Hepato-biliary Disease and Abdominal Transplantation at the University of California, San Diego Health Systems. Dr. Gish has an active research program in viral hepatitis and has published more than 600 original articles, abstracts, and book chapters, and more than 120 peer-reviewed publications.
The Centers for Medicare & Medicaid Services (CMS)
invites you to participate in a webinar to learn more about the Single, Streamlined Application for Health Insurance.
This webinar will walk through the recently released proposed Department of Health and Human Services (HHS) Single, Streamlined Application for individuals. The documents include draft paper applications and a list of all potential questions in the online application that individuals will complete to determine their eligibility to purchase coverage through the Health Insurance Marketplace and for insurance affordability programs, including Medicaid, the Children’s Health Insurance Program (CHIP), and advance payments of the premium tax credit (APTC). The documents are available for public comment until February 28, 2013. To show how users may interact dynamically with the online application, CMS has posted two videos demonstrating how an application can be completed.
- If you’d like to view the entire PRA package, visit go.cms.gov/PRA-Listing to view CMS-10440, CMS-10439, and CMS-10438.
- To view the videos demonstrating the application, visit go.cms.gov/PRA-Scenarios
- To comment on the application package, send your feedback to: OMB, Office of Information and Regulatory Affairs, Attention: CMS Desk Officer, Fax Number: (202) 395-6974 or Email: OIRA_submission@omb.eop.gov.
Date: Friday, February 8, 2013
Time: 1:30pm – 3:00pm (EST)
Call-In Number: 877-267-1577 and Passcode: 7290
Date: Monday, February 11, 2013
Time: 1:00pm – 2:30pm (EST)
Call-In Number: 877-267-1577 and Passcode: 5620
National Medicare Education Program (NMEP) Medicare Open Enrollment
Thursday, October 4, 2012 - 2:00 p.m. to 3:30 p.m., EST
Webinar ID: https://webinar.cms.hhs.gov/oewebinar1004
Call-in number: 1-877-267-1577 Meeting ID: 3358
Please join both the Audio Call and the Webinar
The annual Medicare Open Enrollment Period is October 15 – December
7, 2012. It is time for people with Medicare to compare plans and make
sure they have the right health and prescription drug coverage.
This webinar is designed to provide you with an overview of the differences
between the types of Medicare plans and what that means to people with
Medicare, how to compare plans, important issues to consider in choosing
a plan and where you can get more information or assistance on making
a selection. Helpful information about the Annual Open Enrollment campaign,
MA & Part D plan update, Medicare Advantage Landscape, Part D Benefit,
and Medicare Plan finder October update will also be presented.
Please email Anne.Avery@cms.hhs.gov or Janet.Miller2@cms.hhs.gov if
you have questions or suggestions.
Webinar Announcement: CDC Overview of HCV Screening Guidelines
Draft Recommendations for the Identification of Hepatitis C
Virus (HCV) Chronic Infection Among Persons Born during 1945 through
Date: Tuesday, May 29, 2012
Time: 12:30 PM PDT/3:30 PM EDT
To Register: https://caringambassadors.ilinc.com/register/rbzhwwc
To Join: https://caringambassadors.ilinc.com/join/rbzhwwc
Primary Dial-In: 1-469-759-7753
Alternate Dial-In: 1-800-201-2375
Want to prepare your system ahead of time? https://caringambassadors.ilinc.com/systest/rbzhwwc
Introducing the guidelines: John Ward, MD – Division Director,
CDC Division of Viral Hepatitis (DVH)
Supportive Research: Bryce Smith, Ph.D. – Team Lead, Prevention
Research and Evaluation Team, CDC DVH
Community Call to Action: Ryan Clary – Director of Public Policy,
Project Inform & NVHR Executive Committee Secretary
** The document is located at: www.regulations.gov.
Search for Docket ID: CDC_2012_0005. This page will
provide you with the opportunity to view the Federal Register Notice
of the posting of this draft, as well as the actual recommendations.
Comments on the recommendations can be submitted through a link on the
page for the notice
Title: Hepatitis C Patient Assistance Programs
Presentation Schedule: Each Company will do a 15 minute
presentation followed by 15 minutes of Q&A.
Merck CARES 2:30 PM EST/ 11:30 AM PST
Vertex GPS: Guidance and Patient Support 3:00 PM EST/
12:00 PM PST
Genentech Access Solutions Program 3:30 PM EST/ 12:30
Registration Link: https://caringambassadors.ilinc.com/register/fmcmtmw
Please log in at least 10 minutes prior to the start
of the program to ensure connectivity.
FDA Teleconference - May 23, 2011
The Food and Drug Administration (FDA) invites you to participate in
a teleconference briefing to discuss two Direct Acting Antivirals (DAAs)
for the treatment of hepatitis C, boceprevir and telaprevir, that were
discussed at an April 27 -28, 2011 meeting of the FDA Antiviral Drugs
Advisory Committee. DAAs represent a significant addition to the treatment
approach for many patients. However, the dosing regimens may be complex,
and there are treatment issues about which health care providers and
patients should be aware.
The teleconference will be held on Monday, May 23, 2011 from 3:30 PM
to 4:30 PM EDT. The toll-free number is 888-324-7513 . The passcode is
Following a brief introduction by Margaret Hamburg, Commissioner of
the Food and Drug Administration, the briefing will provide an overview
of the clinical trials, primary efficacy, safety, and complexity of dosing
regimens. The briefing will consist of presentations by Debra Birnkrant,
M.D, Director, and Jeffery Murray, Deputy Director, Division of Antiviral
Products, Center for Drug Evaluation and Research (CDER), followed by
an opportunity for questions from call participants. The briefing will
be moderated by Richard Klein, FDA Office of Special Health Issues.
A replay will be available for 30 days, beginning approximately one
hour after the briefing call ends. The recall number is 1.866.419.2882.
No password is required.
Alternatively, you can Download Audio Recording (22 MB) (http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/ucm256712.htm)
The Community Response Webinar
The recording of HHS Action Plan - The Community Response is
To view this recording: https://caringambassadors.ilinc.com/join/ppsmrth
Date & Time: May 16, 2011 at 12:00 PM Pacific Time
On May 12, 2011 HHS will release the first ever national strategy for
viral hepatitis. Join us for this informative webinar as we explore what
the plan does, and what it does not do, from the community perspective.
Learn how you can use the plan to support the addition of viral hepatitis
services into local health policy. As always, we will leave plenty of
time for questions and answers.
About the Presentation Team:
Mr. Clary is the Director of Public Policy at Project Inform. He advocates
at the national, state, and local levels on HIV and hepatitis C policy
issues. He is a co-founder of Hepatitis C Advocates UNITED!, a national
grassroots coalition of advocates working to increase the federal government’s
response to the HCV epidemic.
Mr. Raymond is the Policy Director for the Harm Reduction Coalition
in New York and a Steering Committee member of the National Viral Hepatitis
Roundtable. His work focuses on syringe access, HIV, hepatitis C, and
overdose prevention. He has worked in the field of harm reduction and
syringe exchange for two decades, and provided testimony to the Institute
of Medicine on hepatitis C prevention for people who inject drugs.
Ms. Sandt is the co-founder and Executive Director of the Caring Ambassadors
Program. She has managed the Hepatitis C Program of the Caring Ambassadors
Program since its inception in 1999. Lorren is a co-editor and a contributing
author, to Hepatitis C Choices, 4th Edition, a one-of-a-kind, patient-centered
book authored by a team of more than 25 multi-disciplined experts in
hepatitis C. She has worked on policy changes at both the state and federal
level since 2001. Lorren is the Chair of the National Viral Hepatitis
Roundtable, a member of the Hepatitis Community Advisory Board, the Fair
Pricing Coalition, a member of the Hepatitis Appropriations Partnership,
and co-moderator of Hepatitis C Advocates UNITED.
Mr. Schwartz is the Manager, Viral Hepatitis/Government Relations for
the National Alliance of State & Territorial AIDS Directors (NASTAD).
In this role, he provides program and policy assistance to state health
department viral hepatitis programs and advocates on their behalf with
the Administration, Congress and Federal Agencies. Mr. Schwartz is actively
involved in several national hepatitis advocacy coalitions including
serving as the Coordinator for the Hepatitis Appropriations Partnership
(HAP). He has policy experience in HIV and viral hepatitis, comprehensive
sex education and sexual health, with expertise on Congressional Appropriations
for public health programs.
To register for this webinar: https://caringambassadors.ilinc.com/register/zkycvfp
To join this webinar: https://caringambassadors.ilinc.com/join/zkycvfp
Dial-In: 1-800-201-2375 or 1-469-759-7753 Passcode:
Webcast Information for the April 27 & 28, 2011, Antiviral
Drugs Advisory Committee (AVDAC) Meeting:
The FDA plans to provide a live webcast of the April 27 & 28,
2011, meeting of the Antiviral Drugs Advisory Committee. Please note
that the webcast will not display until the meeting begins at approximately 8:00
a.m. EDT on April 27 & 28, 2011. Also, while the
FDA is working to make webcasts available to the public for all AC meetings
held at the White Oak campus, there are instances where the webcast transmission
is not successful; staff will work to re-establish the transmission as
soon as possible. FDA plans to post archived webcasts after the meeting,
however, in cases where transmission was not successful, archived webcasts
will not be available.
The meeting webcast can be accessed at the following web address: https://collaboration.fda.gov/adac427/ Note:
At the access page, please sign in as a guest. No password is required. See
attached PDF file for more info.
Meeting materials for FDA's committee for telaprevir:
http://www.fda.gov/AdvisoryCommittees/ CommitteesMeetingMaterials/ Drugs/AntiviralDrugsAdvisoryCommittee
Health Reform 101: Learn what people living with hepatitis may gain
from health reform and how we can all defend it.
We are approaching the one year anniversary of the Affordable Care Act
being signed into law. This law has the potential to help many people
living with and at risk for hepatitis B and C. However, the law continues
to be under attack by many in Congress who want to repeal it and/or defund
This webinar will provide an overview of key provisions in the law and
what they mean for our community. We will also provide tips on how you
can communicate with your Members of Congress at home about the need
to protect this law.
Date: Thu, Mar 17, 2011
Time: 03:00 PM EDT
Duration: 1 hour
- Anne Donnelly, Director of Health Care Policy, Project Inform
- Rachel McLean, California Viral Adult Hepatitis Prevention Coordinator
Sponsored by Hepatitis Health Action, the Hepatitis Appropriations
Partnership, the National Viral Hepatitis Roundtable, Caring Ambassadors
Program, Association of Asian Pacific Community Health Organizations.
Title: Hepatitis Advocacy At Home
Our elected officials have told us again that they want to hear from
their constituents. They have set aside time at home to listen. It is
up to you to speak. Learn what simple action steps you can take next
week to help people living with hepatitis B or C.
The recording of "Hepatitis Advocacy At Home" is
available. To view this recording: https://caringambassadors.ilinc.com/join/jjtrzmk.
Please login to review the recording.
About the Presenters
Corinna Dan, RN, MPH, is the Hepatitis B Fellow at
the Association of Asian Pacific Community Health Organizations (AAPCHO).
Colin Schwartz, Colin Schwartz, Senior Associate, Viral
Hepatitis/Government Relations National Alliance of State & Territorial
Title: Hepatitis Advocacy At Home
Date & Time: 02/18/2011 at 12:00 PM Pacific Time/
3PM Eastern Time
Duration: 1 hour(s)
for Health Care Reform and CDC’s Viral Hepatitis Program are
in Jeopardy (PDF format)
This webinar is a collaborative effort of the Caring Ambassadors Program
(CAP), Hepatitis Appropriations Partnership (HAP), National Viral Hepatitis
Roundtable (NVHR) and Association of Asian Pacific Community Health Organizations
Please distribute widely!
Leveraging the IOM Report on Viral Hepatitis
Audio and Slide Presentation: Leveraging the IOM Report
The National Viral Hepatitis Roundtable, in partnership with the Caring
Ambassadors Program are pleased to announce a webinar on January 12,
2010, for advocates to learn about the Institute of Medicine's
Report on Viral Hepatitis that is being released to the public
on Monday, January 11, 2010. Hear what it says and learn how you can
leverage the findings to advocate for viral hepatitis programs and services
in your area.